Transgenomic (TBIO) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mail
Get Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
BASIC AND DILUTED LOSS PER COMMON SHARE: -0.08
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
BASIC AND DILUTED LOSS PER COMMON SHARE: -0.08
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q4 EPS of ($0.28), $0.13 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $7.2 million.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Investing.com’s stocks of the week
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
